Annual Retained Earnings
-$915.77 M
-$35.14 M-3.99%
December 31, 2023
Summary
- As of February 7, 2025, TCRT annual retained earnings is -$915.77 million, with the most recent change of -$35.14 million (-3.99%) on December 31, 2023.
- During the last 3 years, TCRT annual retained earnings has fallen by -$151.67 million (-19.85%).
- TCRT annual retained earnings is now -537006.74% below its all-time high of -$170.50 thousand, reached on December 31, 2001.
Performance
TCRT Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$919.70 M
-$1.13 M-0.12%
September 30, 2024
Summary
- As of February 7, 2025, TCRT quarterly retained earnings is -$919.70 million, with the most recent change of -$1.13 million (-0.12%) on September 30, 2024.
- Over the past year, TCRT quarterly retained earnings has dropped by -$1.13 million (-0.12%).
- TCRT quarterly retained earnings is now -746412.99% below its all-time high of -$123.20 thousand, reached on June 30, 2001.
Performance
TCRT Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
TCRT Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.0% | -0.1% |
| 3 y3 years | -19.9% | -10.7% |
| 5 y5 years | -61.7% | -24.1% |
TCRT Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.7% | at low | -9.1% | at low |
| 5 y | 5-year | -33.9% | at low | -34.4% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Alaunos Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$919.70 M(+0.1%) |
| Jun 2024 | - | -$918.58 M(+0.1%) |
| Mar 2024 | - | -$917.45 M(+0.2%) |
| Dec 2023 | -$915.77 M(+4.0%) | -$915.77 M(+0.9%) |
| Sep 2023 | - | -$907.92 M(+0.9%) |
| Jun 2023 | - | -$899.45 M(+1.0%) |
| Mar 2023 | - | -$890.67 M(+1.1%) |
| Dec 2022 | -$880.63 M(+4.5%) | -$880.63 M(+1.1%) |
| Sep 2022 | - | -$871.47 M(+1.0%) |
| Jun 2022 | - | -$862.57 M(+1.2%) |
| Mar 2022 | - | -$852.64 M(+1.2%) |
| Dec 2021 | -$842.85 M(+10.3%) | -$842.85 M(+1.4%) |
| Sep 2021 | - | -$831.06 M(+2.8%) |
| Jun 2021 | - | -$808.33 M(+2.9%) |
| Mar 2021 | - | -$785.65 M(+2.8%) |
| Dec 2020 | -$764.10 M(+11.7%) | -$764.10 M(+3.1%) |
| Sep 2020 | - | -$741.33 M(+2.8%) |
| Jun 2020 | - | -$721.01 M(+2.6%) |
| Mar 2020 | - | -$702.42 M(+2.7%) |
| Dec 2019 | -$684.13 M(+20.8%) | -$684.13 M(+2.4%) |
| Sep 2019 | - | -$668.38 M(+12.4%) |
| Jun 2019 | - | -$594.38 M(+2.5%) |
| Mar 2019 | - | -$579.76 M(+2.4%) |
| Dec 2018 | -$566.33 M(-20.5%) | -$566.33 M(-25.6%) |
| Sep 2018 | - | -$761.21 M(+1.7%) |
| Jun 2018 | - | -$748.62 M(+1.6%) |
| Mar 2018 | - | -$736.59 M(+3.4%) |
| Dec 2017 | -$712.44 M(+8.3%) | -$712.44 M(+1.9%) |
| Sep 2017 | - | -$699.17 M(+1.9%) |
| Jun 2017 | - | -$686.47 M(+1.9%) |
| Mar 2017 | - | -$673.61 M(+2.4%) |
| Dec 2016 | -$658.00 M(+33.5%) | -$658.00 M(+1.7%) |
| Sep 2016 | - | -$646.77 M(+1.7%) |
| Jun 2016 | - | -$635.92 M(+26.0%) |
| Mar 2016 | - | -$504.72 M(+2.4%) |
| Dec 2015 | -$492.70 M(+32.2%) | -$492.70 M(+2.0%) |
| Sep 2015 | - | -$483.22 M(+3.9%) |
| Jun 2015 | - | -$465.05 M(+3.2%) |
| Mar 2015 | - | -$450.84 M(+21.0%) |
| Dec 2014 | -$372.61 M(+9.3%) | -$372.61 M(+2.9%) |
| Sep 2014 | - | -$362.21 M(+1.7%) |
| Jun 2014 | - | -$356.12 M(+1.6%) |
| Mar 2014 | - | -$350.54 M(+2.8%) |
| Dec 2013 | -$340.83 M(+20.1%) | -$340.83 M(+2.7%) |
| Sep 2013 | - | -$331.93 M(+5.3%) |
| Jun 2013 | - | -$315.21 M(+6.3%) |
| Mar 2013 | - | -$296.52 M(+4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | -$283.72 M(+51.2%) | -$283.72 M(+11.9%) |
| Sep 2012 | - | -$253.50 M(+7.6%) |
| Jun 2012 | - | -$235.68 M(+11.1%) |
| Mar 2012 | - | -$212.06 M(+13.0%) |
| Dec 2011 | -$187.59 M(+51.5%) | -$187.59 M(+7.6%) |
| Sep 2011 | - | -$174.35 M(+0.5%) |
| Jun 2011 | - | -$173.55 M(+6.6%) |
| Mar 2011 | - | -$162.82 M(+31.5%) |
| Dec 2010 | -$123.81 M(+35.8%) | -$123.81 M(+10.6%) |
| Sep 2010 | - | -$111.96 M(+12.2%) |
| Jun 2010 | - | -$99.76 M(-8.3%) |
| Mar 2010 | - | -$108.80 M(+19.4%) |
| Dec 2009 | -$91.14 M(+7.2%) | -$91.14 M(-1.0%) |
| Sep 2009 | - | -$92.11 M(+3.2%) |
| Jun 2009 | - | -$89.23 M(+2.8%) |
| Mar 2009 | - | -$86.83 M(+2.1%) |
| Dec 2008 | -$85.06 M(+42.2%) | -$85.06 M(+5.7%) |
| Sep 2008 | - | -$80.50 M(+7.4%) |
| Jun 2008 | - | -$74.95 M(+9.5%) |
| Mar 2008 | - | -$68.45 M(+14.4%) |
| Dec 2007 | -$59.83 M(+80.1%) | -$59.83 M(+14.8%) |
| Sep 2007 | - | -$52.13 M(+16.3%) |
| Jun 2007 | - | -$44.81 M(+17.1%) |
| Mar 2007 | - | -$38.26 M(+15.2%) |
| Dec 2006 | -$33.22 M(+116.2%) | -$33.22 M(+21.2%) |
| Sep 2006 | - | -$27.40 M(+14.4%) |
| Jun 2006 | - | -$23.95 M(+28.9%) |
| Mar 2006 | - | -$18.58 M(+21.0%) |
| Dec 2005 | -$15.36 M(+162.8%) | -$15.36 M(+19.1%) |
| Sep 2005 | - | -$12.90 M(+4051.6%) |
| Jun 2005 | - | -$310.80 K(+3.3%) |
| Mar 2005 | - | -$300.80 K(-94.9%) |
| Dec 2004 | -$5.85 M(+2274.1%) | -$5.85 M(+2027.1%) |
| Sep 2004 | - | -$274.90 K(+2.1%) |
| Jun 2004 | - | -$269.20 K(+6.4%) |
| Mar 2004 | - | -$253.00 K(+2.7%) |
| Dec 2003 | -$246.30 K(+17.0%) | -$246.30 K(+4.5%) |
| Sep 2003 | - | -$235.60 K(+3.8%) |
| Jun 2003 | - | -$227.00 K(+3.0%) |
| Mar 2003 | - | -$220.40 K(+4.7%) |
| Dec 2002 | -$210.50 K(+23.5%) | -$210.50 K(+5.4%) |
| Sep 2002 | - | -$199.70 K(+3.4%) |
| Jun 2002 | - | -$193.20 K(+7.5%) |
| Mar 2002 | - | -$179.80 K(+5.5%) |
| Dec 2001 | -$170.50 K | -$170.50 K(+31.1%) |
| Sep 2001 | - | -$130.10 K(+5.6%) |
| Jun 2001 | - | -$123.20 K |
FAQ
- What is Alaunos Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Alaunos Therapeutics?
- What is Alaunos Therapeutics annual retained earnings year-on-year change?
- What is Alaunos Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Alaunos Therapeutics?
- What is Alaunos Therapeutics quarterly retained earnings year-on-year change?
What is Alaunos Therapeutics annual retained earnings?
The current annual retained earnings of TCRT is -$915.77 M
What is the all time high annual retained earnings for Alaunos Therapeutics?
Alaunos Therapeutics all-time high annual retained earnings is -$170.50 K
What is Alaunos Therapeutics annual retained earnings year-on-year change?
Over the past year, TCRT annual retained earnings has changed by -$35.14 M (-3.99%)
What is Alaunos Therapeutics quarterly retained earnings?
The current quarterly retained earnings of TCRT is -$919.70 M
What is the all time high quarterly retained earnings for Alaunos Therapeutics?
Alaunos Therapeutics all-time high quarterly retained earnings is -$123.20 K
What is Alaunos Therapeutics quarterly retained earnings year-on-year change?
Over the past year, TCRT quarterly retained earnings has changed by -$1.13 M (-0.12%)